<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02019511</url>
  </required_header>
  <id_info>
    <org_study_id>RH-0703</org_study_id>
    <nct_id>NCT02019511</nct_id>
  </id_info>
  <brief_title>Safety Study of High-dose Methylprednisolone in Fast-track Total Knee Arthroplasty</brief_title>
  <official_title>Safety Aspects of High-Dose Methylprednisolone in Fast-track Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Lundbeck Foundation Centre for Fast-track Hip and Knee Arthroplasty</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been shown that a single high dose of steroid before surgery may reduce pain the first
      48 hours after insertion of a new joint in the knee, a so called &quot;total knee arthroplasty&quot;
      (TKA). Consequently, this has been introduced as standard treatment of most patients at
      several Danish orthopedic departments. Although there are some concerns about the possibility
      of increased risk of prosthesis infections, this has not been proved in previous studies.
      However the studies are few, have limited number of patients and are not done using a
      standardized perioperative set-up.

      This study is made to monitor the safety of a single high dose steroid injection before TKA,
      with regards to prosthesis infection within one year of surgery.

      We hypothesize that there will be no increase in infections in patients receiving steroid
      injection before TKA compared to a historical cohort of patents who did not receive a steroid
      injection before their TKA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to reduce pain intensity as much as possible after surgical procedures, modern
      multimodal analgesic strategies using different analgetics targeting different mechanism of
      the pain reception system are used. At the same time this may reduce the use of opioids,
      which commonly cause sideeffects such as nausea, vomiting, obstipation,urinary retention,
      itching, respiratory suppression and sedation.

      In spite of the use of a wide perioperative multimodal analgesia, pain after total knee
      arthroplasty (TKA), is stil a considerable clinical problem and need for optimisation of the
      immediate postoperative pain treatment. There is evidence that &quot;high&quot;dose glucocorticoids
      administered preoperatively reduces the level of pain and the use of opioids after surgery. A
      recent review did not give cause for concern regarding use of glucocorticoids in TKA,but
      found that data on longterm safety aspects are lacking, why no recommendations could be made.

      As the limited evidence presently points to af benefit of glucocorticoids without serious
      side effects, the treatment has been introduced as standard treatment in TKA at several of
      the departments participating in the Lundbeck Foundation Centre for fast-track Hip and Knee
      Replacement collaboration.

      This study is made to monitor the safety of high dose steroid injection before TKA, with
      regards to prosthesis infection within one year of surgery.

      We hypothesize that there will be no increase in infections in patients receiving steroid
      injection before TKA compared to a historical cohort of patents who did not receive a steroid
      injection before their TKA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>prosthesis related infections within 1 year after TKA</measure>
    <time_frame>1 year</time_frame>
    <description>Causes if infection are subdivided into the following:
Deep prosthesis related infection
Superficial infection (defined as surgery verified infection above level of the fascia)
Clinical / paraclinical suspicion of infection only treated with intravenous antibiotics (no surgical procedure)
Possible infection, but no clinical/paraclinical suspicion of infection, why the patient is discharged without intravenous antibiotic treatment/surgery.
Surgical wound revision (no clinical/paraclinical suspicion of infection)
Surgical knee manipulation due to limited range of movement (no clinical/paraclinical suspicion of infection).
Surgery due to aseptic non-traumatic loosening of the knee.
Surgery due to traumatic loosening of the knee</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency and cause of hospital stay &gt;4 days</measure>
    <time_frame>primary admission</time_frame>
    <description>Patients admitted for &gt;4 days will have their discharge files reviewed with regards to causes of this prolonged&quot; stay. This in accordance with the method used in the Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement registry trials (Clinicaltrials.gov identifier:NCT01515670)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency and causes of 90 days readmissions</measure>
    <time_frame>90 days after surgery</time_frame>
    <description>These will be found through review of medical files and defined as readmission possibly related to surgery and with overnight stay in hospital. These will be classified according to the method used in the ongoing trials in the Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement registry (Clin.trials ID:NCT01515670)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequencies and causes of readmissions to orthopedic departments 12 months after TKA.</measure>
    <time_frame>1 year</time_frame>
    <description>These will be found through review of medical files and classified appropriately into broad categories depending on data. Detailed information on each case will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>90 days and 1 year</time_frame>
    <description>Incidence of 90 days and 1 year mortality will be reported</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Prosthesis related infections 24 months after TKA</measure>
    <time_frame>2 years</time_frame>
    <description>A separate outcome regarding incidence of prosthesis related infections, as defined in the primary outcome, is planned. This will not be part of the initial study, but is planned to be an independent follow-up study</description>
  </other_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Infection of Total Knee Joint Prosthesis</condition>
  <arm_group>
    <arm_group_label>High dose Steroid</arm_group_label>
    <description>Patients scheduled for primary unilateral elective TKA Age &gt;17 years
none of the following contraindications for Methylprednisolone:
Allergy against Methylprednisolone.
Currently in systemic treatment with glucocorticoid
Current gastric ulcer
Insulin dependent diabetes mellitus
Citizens without Danish social security number are not eligible for this study as follow-up is not possible.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Historical cohort</arm_group_label>
    <description>Patients having primary unilateral elective TKA before initiation of Methylprednisolone as standard treatment
age &gt;17 years, Danish social security number
and none of the following at time of surgery:
systemic treatment with glucocorticoid defined as: regular prescriptions on glucocorticoid within 2 months prior to surgery.
gastric ulcer defined as: prescriptions on drugs used in &quot;triple therapy&quot; for Helicobacter Pylori infection or prescriptions on antiacids/proton pump inhibitors beginning 1 month before surgery
Insulin dependent diabetes mellitus defined as: any prescriptions on insulin within 6 months prior to surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Procedures without Steroid</arm_group_label>
    <description>Patients scheduled for primary unilateral elective TKA and age &gt;17 years but who did not receive high dose Methylprednisolone regardless of reason.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive unselcted patients with unilateral elective total fast-track knee arthroplasty
        in a standardized perioperative set-up and with completed prospective registration of
        preoperative chartacteristics and co-morbidity
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for primary unilateral elective TKA and no contraindications for
             high-dose Methylprednisolone preoperatively

          -  Danish Social security number

        Exclusion Criteria:

        One of the following contraindications for Methylprednisolone:

          -  Allergy against Methylprednisolone.

          -  Currently in systemic treatment with glucocorticoid

          -  Current gastric ulcer

          -  Insulin dependent diabetes mellitus

        Further contraindications are at the discretion of the individual department/surgeon. The
        cohort without preoperative Methylprednisolone treatment will be followed as a separate
        cohort to identify potential selection bias.

        - Citizens without Danish social security number are not eligible for this study as
        follow-up is not possible.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoffer C JÃ¸rgensen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Section for Surgical Pathophysiology Copenhagen University, Rigshospitalet</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Troels H Lunn, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Section for Surgical Pathophysiology, Copenhagen University, Rigshospitalet</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henrik Kehlet, MD Prof PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Secton for Surgical Pathophysiology, Copenhagen University , Rigshospitalet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <state>Judland</state>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Farsoe Hospital</name>
      <address>
        <city>Farsoe</city>
        <state>Judland</state>
        <zip>9640</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sydvestjydsk Sygehus</name>
      <address>
        <city>Grindsted</city>
        <state>Judland</state>
        <zip>7200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holstebro Hospital</name>
      <address>
        <city>Holstebro</city>
        <state>Judland</state>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vejle Hospital</name>
      <address>
        <city>Vejle</city>
        <state>Judland</state>
        <zip>7100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Viborg Hospital</name>
      <address>
        <city>Viborg</city>
        <state>Judland</state>
        <zip>8800</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gentofte University Hospital</name>
      <address>
        <city>Gentofte</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://fthk.dk</url>
    <description>webpage of the Lundbeck Foundation Centre for fast-track Hip and Knee Replacement</description>
  </link>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2013</study_first_submitted>
  <study_first_submitted_qc>December 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2013</study_first_posted>
  <last_update_submitted>April 18, 2017</last_update_submitted>
  <last_update_submitted_qc>April 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Christoffer Joergensen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Orthopedic surgery</keyword>
  <keyword>Infections</keyword>
  <keyword>Steroid</keyword>
  <keyword>Fast-track</keyword>
  <keyword>Total knee arthroplasty</keyword>
  <keyword>Safety</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

